Thyroid medication recall
(KUTV) - Westminster Pharmaceuticals, LCC, is voluntarily recalling two thyroid medications to the wholesale level.
Levothyroxine and Liothyronine (Thyroid Tablets (USP) are voluntarily recalled for precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the Food and Drug Administration's (FDA) import alert of Sichuan Friendly Pharmaceutical Co., Ltd., as a result of an inspection were found to have deficiencies with Current Good Manufacturing Practices (cGMP). Substandard cGMP practices could represent the possibility of risk being introduced into manufacturing processes.
The thyroid tablets that are being recalled are the 15, 30, 60, 90 and 120 mg. dosages, according to the FDA.
To date, Westminster Pharmaceuticals has not received any reports of adverse events related to the medication. Because the thyroid tablets may be used in treatment of serious medical conditions, patients taking recalled medicine should continue taking the medicine until they have a replacement product.
Westminster Pharmaceuticals is notifying its direct accounts by email and phone to immediately discontinue distribution of the recalled medication and to notify their sub-wholesale accounts of the product. Consumers that have these thyroid tablets should not discontinue use before contacting their physician for further guidance.